(Press-News.org) A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer women getting guideline-directed medical therapy than men.
As a result, combined with this highly debilitating disease, patients with peripheral artery disease have a more than 50 percent chance of dying from the condition.
Peripheral artery disease affects nearly 10 percent of the US population. It occurs when the arteries that carry blood to the legs and arms become narrowed or blocked by plaque buildup, leading to reduced blood flow.
As one of the major conditions that comprise atherosclerotic cardiovascular disease, peripheral artery disease the third leading cause of death from atherosclerotic disease.
“In our study, we found a high rate of non-treatment of peripheral artery disease along with higher levels of mortality in these patients,” said Viet T. Le, DMSc, MPAS, PA-C, primary investigator of the study and associate professor of cardiovascular research at Intermountain Health. “Based on our findings, we think health systems can do a better job at screening patients for peripheral arterial disease and treating them for it. These findings represent an opportunity to improve and implement systems of care, especially for women.”
The Intermountain Health study findings were presented at the American College of Cardiology’s annual scientific sessions conference in Chicago on Sunday, March 30, 2025.
In the study, researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their initial appointment.
Of that group, 38 percent were women and 62 percent men.
Researchers then looked at whether each patient was treated with the guideline-directed medical therapies of an antiplatelet, statin, and other applicable treatments, and their subsequent risk of having either a major cardiac event, like heart attack, stroke or death, or major limb amputation.
Researchers found that only 29.6 percent of women and 33.5 percent of men received all applicable optimal guideline-directed care, with women having similar rates of referrals to specialists but higher rates to primary care providers.
Women were also slightly less likely to suffer a major cardiac event or limb amputation than men. They also found that patients in the study, regardless of their gender, had a 50 percent chance of dying, Le said.
“Every single person in these groups should have at least received antiplatelet therapy and statin. Instead, only about one in three did, which demonstrates the need to enhance methods to identify and treat peripheral artery disease,” said Le.
These results aren’t necessarily because clinicians don’t care or are not aware of guidelines, he added. Instead, the low rate of prescribing is most likely due to significant challenges in identifying and treating peripheral arterial disease versus other kinds of atherosclerotic disease.
For example, he said, a patient complaining of leg pain can be seen as having a vague complaint, one possibly caused by a range of health or medical conditions. Plus, leg pain can be treated by different types of clinicians, and they may not be up to date on peripheral artery disease or the best possible treatments for it.
Cardiologists may also focus on treating heart disease or preventing stroke, and believe these measures also address peripheral arterial disease, when patients should be screened and treated specifically for that condition, noted Le.
“We can certainly do a better job of screening for peripheral arterial disease and treating it as its own condition,” said Le. “We should not be seeing a 50% death rate among these patients. With development and implementation of better disease screening and treatment monitoring, we can increase appropriate treatment for these patients, and lower death rates.”
Symptoms of peripheral artery disease often include cold feet, aching or cramping in the feet during activity, and leg ulcers. While anyone can develop peripheral artery disease, the risk for the condition increases as people age, and in the United States, it more frequently occurs in people over 65.
While peripheral arterial disease cannot be cured, lifestyle changes, medication, and other treatments, including surgical procedures, can reduce symptoms, improve the quality of life for patients, and help slow or prevent the progression of the disease.
###
END
New study finds peripheral artery disease often underdiagnosed and undertreated; opportunity to improve treatments, lower death rates
2025-03-30
ELSE PRESS RELEASES FROM THIS DATE:
Use of antidepressant medication linked to substantial increase in risk of sudden cardiac death
2025-03-30
Vienna, Austria- 30 March 2025
Sudden cardiac death (SCD) refers to an unexpected death of a person, believed to be caused by a heart-related issue. It occurs within one hour of the onset of symptoms in witnessed cases or within 24 hours of the person being last seen alive in unwitnessed cases.
The causes in people under the age of 39 are often a thickening of the heart muscle or an electrical problem with the heart. In older people, SCD is more likely to be caused by a narrowing of the blood vessels that supply the heart.
Previous research has shown1 that patients with psychiatric disorders have an increased all-cause mortality ...
Atrial fibrillation diagnosed in midlife is linked to a 21% increased risk of dementia at any age and a 36% higher risk of early-onset dementia
2025-03-30
Vienna, Austria- 31 March 2025
New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation (AF) increases the risk of future dementia by 21% in patients diagnosed with AF under 70 and the risk of early-onset dementia (diagnosed before age 65 years) by 36%. The association was stronger in younger adults and was lost in older adults aged 70 years and over.
“This is the largest European population-based study evaluating the association between AF and dementia,” say the authors that include Dr Julián Rodriguez ...
Mode of death in patients with heart failure with mildly reduced or preserved ejection fraction
2025-03-30
About The Study: Among patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure randomized clinical trial, higher proportions of cardiovascular and overall mortality in those with ejection fraction less than 50% were related principally to higher proportions of sudden death. A clear treatment effect of finerenone on cardiovascular or cause-specific mortality was not identified, although the trial was likely underpowered for these outcomes.
Corresponding Author: To contact the corresponding author, Akshay S. Desai, ...
Intravenous ferric carboxymaltose in heart failure with iron deficiency
2025-03-30
About The Study: In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in the overall cohort or in patients with a transferrin saturation less than 20%, or reduce the total number of heart failure hospitalizations vs placebo.
Corresponding Author: To contact the corresponding author, Stefan D. Anker, MD, PhD, email s.anker@cachexia.de.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.3833)
Editor’s ...
Artificial intelligence in the prevention of sudden death
2025-03-30
Many cases of sudden cardiac death could be avoided thanks to artificial intelligence. As part of a new study to be published in European Heart Journal, a network of artificial neurons imitating the human brain was developed by researchers from Inserm, Paris Cité University and the Paris public hospitals group (AP-HP), in collaboration with their colleagues in the USA. During the analysis of data from over 240 000 ambulatory electrocardiograms, this algorithm identified patients at risk of a serious arrhythmia that was capable of triggering cardiac arrest within the following 2 weeks in over 70% of cases.
Each ...
Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes
2025-03-29
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.
A new clinical trial, co-led by endocrinologist and diabetes expert John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine has shown that the oral form of semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes, atherosclerotic cardiovascular disease, and/or ...
Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery
2025-03-29
About The Study: In this unblinded randomized clinical trial, prothrombin complex concentrate had superior hemostatic efficacy and safety advantages to frozen plasma among patients requiring coagulation factor replacement for bleeding during cardiac surgery.
Corresponding Author: To contact the corresponding author, Keyvan Karkouti, MD, email keyvan.karkouti@uhn.ca.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.3501)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, ...
Who needs a statin? New study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring
2025-03-29
A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease and which patients would benefit from taking a statin medication to lower cholesterol.
Currently, cardiologists determine a patient’s need for a statin based on traditional risk factors, using the Pooled Cohort Equation (PCE), which calculates coronary risk by assessing the risk factors of age, sex, total and HDL cholesterol levels, blood pressure, and whether someone ...
Finerenone and atrial fibrillation in heart failure
2025-03-29
About The Study: The efficacy of finerenone was consistent regardless of atrial fibrillation status in this study. New-onset atrial fibrillation was associated with a substantially higher risk of subsequent outcomes.
Corresponding Author: To contact the corresponding author, John J. V. McMurray, MD, email john.mcmurray@glasgow.ac.uk.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamacardio.2025.0848)
Editor’s Note: Please see the article for additional information, including other authors, ...
Low coronary artery calcium score is associated with an excellent prognosis regardless of a person’s age, new study finds
2025-03-29
Having a coronary artery calcium (CAC) score of zero has generally been accepted as a marker of a very low risk of having a cardiac event within the next five years. However, age is a strong contributor to coronary risk, with risk increasing markedly as people age.
Whether age-related risk factors diminish the low risk predicted by a zero coronary artery calcium score has been uncertain – until now.
A large new study of more than 40,000 patients from heart researchers at Intermountain Health in Salt Lake City finds that a zero coronary artery calcium score continues to be an accurate indicator of a low risk for a coronary ...